Quite recently, kinetin was shown to increase the inclusion levels of exon 20 of IκB kinase complex-associated protein (IKBKAP) in cells derived from familial dysautonomia (FD) patients; however, the effective dosage (10 μM) of kinetin in FD patients led to severe toxicity effects20. The gene discussed is ELP1; the disease is Fabry disease.